Cancer Vaccines To Pay Off? Pivotal Candidates May Yield Two BLAs In 2006
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA appears likely to review both personalized and "off-the-shelf" cancer vaccine BLAs in 2006, potentially rewarding the oncology community’s durable faith in active immunotherapy.